| Issue Date | Title | Involved Person(s) |
| 19-Apr-2021 | Back Cover: Antiprotozoal structure–activity relationships of synthetic leucinostatin derivatives and elucidation of their mode of action (Angew. Chem. Int. Ed. 28/2021) | Brand, Michael; Wang, Lei; Agnello, Stefano; Gazzola, Silvia; Gall, Flavio M.; Raguž, Luka; Kaiser, Marcel; Schmidt, Remo S.; Ritschl, Amélie; Jelk, Jennifer; Hemphill, Andrew; Mäser, Pascal; Bütikofer, Peter; Adams, Michael; Riedl, Rainer |
| 2017 | Emodin : a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents | Abu Eid, Sameer; Adams, Michael; Scherer, Thomas; Torres-Gómez, Héctor Manuel; Hackl, Martina Theresa; Kaplanian, Mairam; Riedl, Rainer; Luger, Anton; Fürnsinn, Clemens |
| 2017 | Development of a non-hydroxamate dual matrix metalloproteinase (MMP)-7/-13 inhibitor | Fischer, Thomas; Riedl, Rainer |
| 18-Feb-2019 | Titelbild: Von der Natur inspiriertes Wirkstoffdesign : kristallographische Detektion eines selbstgenerierten Inhibitor‐Grundgerüsts (Angew. Chem. 12/2019) | Gall, Flavio M.; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E.; Sievers, Martin; Riedl, Rainer |
| 1-May-2023 | Development of small-molecule drugs for the treatment of leukemia | Riedl, Rainer |
| Sep-2016 | Emodin, a compound with acclaimed antidiabetic potential, deteriorates glucose tolerance in obese mice | Abu Eid, S.; Adams, M.; Scherer, T.; Torres-Gómez, H.; Hackl, M.T.; Riedl, R.; Luger, A.; Fürnsinn, C. |
| 2015 | Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural-product-derived fragments | Lanz, Jan; Riedl, Rainer |
| 1997 | Fluorescence reporters for phosphodiesterase activity | Berkessel, Albrecht; Riedl, Rainer |
| 2017 | Cover profile : targeted fluoro positioning for the discovery of a potent and highly selective matrix metalloproteinase inhibitor | Fischer, Thomas; Riedl, Rainer |
| 25-Sep-2013 | Tackling antibiotic resistance | Riedl, Rainer |
